Indivior Pharmaceuticals Inc (INDV) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $37.51 (+2.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 30, 2025 | Brandon Folkes | H.C. Wainwright | $35.00 | -6.7% |
| Aug 27, 2025 | Chase Knickerbocker | Craig-Hallum | $34.00 | -9.4% |
| Oct 11, 2024 | David Amsellem | Piper Sandler | $15.00 | -60.0% |
| Sep 23, 2024 | Chase Knickerbocker | Craig-Hallum | $20.00 | -46.7% |
| Sep 13, 2024 | David Amsellem | Piper Sandler | $22.00 | -41.3% |
| Jul 10, 2024 | Chase Knickerbocker | Craig-Hallum | $24.00 | -36.0% |
| Apr 3, 2024 | Chase Knickerbocker | Craig-Hallum | $37.00 | -1.4% |
Top Analysts Covering INDV
INDV vs Sector & Market
| Metric | INDV | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +19.1% | +1150.3% | +14.9% |
| P/E Ratio | 22.87 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.13B | $1.16B | $1.19B | 6 |
| 2027-03-31 | $276M | $286M | $294M | 3 |
| 2027-06-30 | $293M | $303M | $311M | 2 |
| 2027-09-30 | $302M | $312M | $321M | 2 |
| 2027-12-31 | $313M | $323M | $332M | 3 |
| 2028-03-31 | $313M | $324M | $333M | 2 |
| 2028-06-30 | $325M | $336M | $345M | 1 |
| 2028-09-30 | $337M | $348M | $358M | 1 |
| 2028-12-31 | $351M | $363M | $373M | 2 |
| 2029-12-31 | $1.33B | $1.36B | $1.40B | 2 |
| 2030-12-31 | $1.34B | $1.38B | $1.42B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.69 | $3.12 | $3.38 | 4 |
| 2027-03-31 | $0.77 | $0.80 | $0.83 | 2 |
| 2027-06-30 | $0.84 | $0.88 | $0.91 | 1 |
| 2027-09-30 | $0.87 | $0.91 | $0.95 | 1 |
| 2027-12-31 | $0.91 | $0.95 | $0.98 | 2 |
| 2028-03-31 | $0.82 | $0.86 | $0.89 | 3 |
| 2028-06-30 | $0.88 | $0.92 | $0.95 | 2 |
| 2028-09-30 | $0.97 | $1.01 | $1.05 | 2 |
| 2028-12-31 | $1.03 | $1.08 | $1.12 | 3 |
| 2029-12-31 | $3.71 | $3.83 | $4.00 | 1 |
| 2030-12-31 | $4.01 | $4.14 | $4.32 | 1 |
Frequently Asked Questions
What is the analyst consensus for INDV?
The consensus among 1 analysts covering Indivior Pharmaceuticals Inc (INDV) is Buy with an average price target of $43.75.
What is the highest price target for INDV?
The highest price target for INDV is $37.00, set by Chase Knickerbocker at Craig-Hallum on 2024-04-03.
What is the lowest price target for INDV?
The lowest price target for INDV is $15.00, set by David Amsellem at Piper Sandler on 2024-10-11.
How many analysts cover INDV?
1 analysts have issued ratings for Indivior Pharmaceuticals Inc in the past 12 months.
Is INDV a buy or sell right now?
Based on 1 analyst ratings, INDV has a consensus rating of Buy (2.00/5) with a +19.1% upside to the consensus target of $43.75.
What are the earnings estimates for INDV?
Analysts estimate INDV will report EPS of $3.12 for the period ending 2026-12-31, with revenue estimated at $1.16B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.